StockData
Stryker Corp logo

Stryker Corp

SYKNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3020% below fair value
$306.81+14.95 (+5.12%)

Close on Nov 2, 2026Market cap $117.68BP/E 32.7Yield –

Stryker Stryker by Year

Stryker — U.S. FDA Premarket Approvals (PMA & Supplements, approvals)

Stryker Stryker: 7 in FY2025, down 53.3% from a year earlier.

Latest, FY2025
7
Period ended Dec 31, 2025
Change on a year earlier
-53.3%
15 in FY2024
History
12 years
Since FY2014
Sources
1
U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker

Where the FY2025 figure comes from

Source: U.S. FDA openFDA Device Clearances, PMA, Recalls & MAUDE — Stryker ↗

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

Cite this data

StockData. (2026). Stryker Stryker, annual FY2014–FY2025 [Data set]. Compiled from Stryker SEC filings and investor materials. https://stockdatahq.com/stocks/syk/kpis/ext-fda-pma

See every metric in the Stryker KPI table. Data updated Nov 2, 2026.